Silicon Genetics Announces GeNet Wins at Bayer and Celltech R&D

REDWOOD CITY, CA -- Silicon Genetics, a leading provider in gene expression informatics solutions, announced today two major deployments of its enterprise software product, GeNet(TM). The companies are Bayer Corporation, a major pharmaceutical company and Celltech R&D, a subsidiary of the Celltech Group plc, a major biotechnology company. The enterprise software GeNet, in conjunction with GeneSpring(TM), provides companies with an integrated gene expression informatics solution. This offers advanced analysis and visualization tools, along with a centralized server database to store, retrieve, analyze, and share large volumes of gene expression data. GeneSpring, the desktop component of Silicon Genetics' scalable enterprise solution, is widely used by researchers to decipher vast quantities of gene expression information. "Silicon Genetics' products provide customers with the ability to handle the demands of large amounts of expression data storage and distribution as a result of significant research and development efforts within an organization," said Saeid Akhtari, COO of Silicon Genetics. "GeNet is a unique product that combines the power of GeneSpring to create a sophisticated data analysis and management environment to give researchers a revolutionary enterprise-wide level informatics solution to their data overflow." "I strongly believe the flexibility and scalability of Silicon Genetics informatics technology will help us with our research and development growth worldwide," said Mark Evans, Sr. Research Scientist of Bayer Corporation. "GeNet, along with GeneSpring, offers a valuable addition to our global research capabilities." For further information visit www.sigenetics.com